ABOUT THE JOURNAL

• Aims and scope of journal |
• Abstracted/indexed in |
• ISSN and eISSN |
• Editors |

Aims and scope of journal

Under the guidance of a highly respected Editor and an expert Editorial Board each quarterly issue publishes analyses, briefings and updates which are of direct relevance to practitioners and that meet the highest intellectual standards.

Subscribing to Journal of Generic Medicines will give you and your organization access to the latest thinking from some of the world's leading authorities, including articles on:

• strategies for challenging and protecting patents
• pricing and reimbursement trends and policies - country by country
• fair and unfair tactics to block generic competition
• patent expiries and their impact on national, regional and global markets
• business development strategies and licensing agreements
• clinical trials and bioequivalence studies
• m&a strategy
• regulatory affairs
• major buyers' tender procedures
• data exclusivity and patents
• manufacturing and outsourcing
• briefings from government agencies
• marketing and branding strategies
• strategies for challenging innovators
• analysis of disease sectors
• own brand markets
• R&D
• legal briefings - including case law discussions
• market reviews
• the OTC generic market
• packaging and labelling
• biogenerics
• purchase strategies

Abstracted/indexed in

• EMBASE
• SCOPUS

ISSN and eISSN

The international standard serial number (ISSN) for Journal of Generic Medicines is 1741-1343 and the electronic international standard serial number (eISSN) is 1741-7090.

Editors

Editor

Greg Perry, Director General, European Generic Medicines Association, Belgium

Editorial Advisory Board

Nicholas F. Cappuccino, Chief Scientific Officer, Eagle Pharmaceuticals, Inc., USA
Richard DiCicco, President, Technology Catalysts International, USA
Tommy Erdei, Executive Director, Global Healthcare Group, UBS Investment Bank, UK
Jean Hoffman, President, Putney, Inc., USA
M. Fabiana Jorge, President, MFJ International, LLC, USA
Dr Yehudah Livneh, General Patent Counsel, Teva Pharmaceutical Industries Limited, Israel
Paolo Romagnoli, President, Romagnoli Consulting, Milan, Italy
Rory O'Riordan, CEO, Clonmel Healthcare and President, Stada Inc, Ireland
Warwick Smith, Director, British Generic Manufacturers Association, UK
Dr Brian Tempest, Chief Mentor & Vice Chairman of the Board, Ranbaxy Laboratories Ltd., India

Association/Regional Advisors

USA: GPhA President and CEO Kathleen Jaeger
Canada and Africa: CGPA President Jim Keon
India and Asia (exc Japan): IPA Secretary General Dilip G. Shah
Europe: EGA Head of Communications & PR Roy Gentry
Latin America: Pró Genéricos Executive Director Vera Valente
Japan: IGPA Committee of JGPMA, Vice chairman Juichi Riku
Australasia: GMiA Executive Director Di Ford

Editorial Board

Professor Henning Blume, President & CEO, SocraTec R&D GmbH, Germany
Dr. C. Anthony Butler, Pharmaceutical/biotechnology industry
analyst, Co-head of Global Pharmaceuticals and a Managing Director, Lehman Brothers Pharmaceutical Research, USA
Professor Carlos Correa, Director of the Center for Interdisciplinary Studies on Industrial Property Law and Economics, CEIDIE, Argentina
Professor Graham Dukes, Professor of Pharmacotherapy, University of Oslo, Norway
Richard Eggleston, Research and Development Director, Galpharm International Ltd, UK
Eric B. Fastiff, Partner, Lieff, Cabraser, Heimann & Bernstein, LLP, USA
Nicholas M. Fleischer, Vice- President, Clinical Pharmacology and Biopharmaceutics, The Weinberg Group Inc., USA
Dr Torsten Goesch, BioSciences Managers Ltd, Germany
William F. Haddad, Chairman/CEO, Biogenerics, Inc, USA
Dr Juhana Idänpään-Heikkilä, Secretary-General, CIOMS c/o WHO, Switzerland
Gordon Johnston, Vice President of Regulatory Affairs, Generic Pharmaceutical Industry Association, USA
Dr Bruce Painter, Pharmacy Divisional Merchandise Manager, Wal-Mart Pharmacy, USA
Jean-Michel Peny, President, Smart Pharma Consulting, France
Steve Self, Group R&D Director, Generics [UK] Limited, UK
Prafull Sheth, Immediate Past President, Indian Pharmaceutical Association, India
Richard Silver, Senior Vice President, Equity Research, Lehman Brothers Pharmaceutical Research, USA
Howard Stokoe, Principal Pharmacist, NHS Purchasing and Supply Agency, UK
Guy Villax, Chief Executive, Hovione, Portugal
Professor Emeritus Bozidar Vrhovac, Medical School University of Zagreb, Croatia
Dr Lawrence Yu, Director for Science, Office of Generic Drugs, Food and Drug Administration and adjunct Professor of Pharmaceutical Engineering, University of Michigan, USA

US Legal Update Editor

Neil Greenblum, Co-managing partner, Greenblum & Bernstein PLC, USA

EU Legal Update Editor

Richard Milchior, SCP Granrut Avocats, France

Editor of Patent Expiry Impact Predictor Regular Feature

Joanna Chertkow, Lead Analyst, Strategic Intelligence, Datamonitor Healthcare, UK

EU Case Reports Editor

Michael Burdon, Partner, Head of Biosciences Group, Olswang, UK

US Case Reports Editor

Frederick H. Rein, Partner, Goodwin Procter LLP, USA

Editorial Office

• Neil Henderson
  Publishing Manager
  Palgrave Macmillan
  Houndmills
  Basingstoke RG21 6XS, UK
  E-mail: n.henderson@palgrave.com
  Please clearly state for which journal you are contributing.